|
1
|
Altundag K, Babacan T, Efe O, Hasırcı AS, Demirci F, Buyukhatıpoglu H, Balakan O, Sarıcı FS, Kertmen N, Esin E, Akin S, Ates O, Aksoy S, Sever AR. Efficacy of capecitabine monotherapy as the first-line treatment of metastatic HER-2 negative breast cancer. J Clin Oncol 2015. [DOI: 10.1200/jco.2015.33.15_suppl.e12035] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- Kadri Altundag
- Hacettepe University Cancer Institute, Department of Medical Oncology, Ankara, Turkey
| | - Taner Babacan
- Department of Medical Oncology, Hacettepe University Institute of Oncology, Ankara, Turkey
| | - Orhan Efe
- Hacettepe Univesity Cancer Institute, Ankara, Turkey
| | | | - Fatih Demirci
- Hacettepe Univesity Cancer Institute, Ankara, Turkey
| | | | - Ozan Balakan
- Gaziantep University, Medical Oncology Department, Gaziantep, Turkey
| | | | - Neyran Kertmen
- Hacettepe University Institute of Cancer, Medical Oncology Department, Ankara, Turkey
| | - Ece Esin
- Hacettepe University, Oncology Institute, Medical Oncology Department, Ankara, TN, Turkey
| | - Serkan Akin
- Hacettepe Univesity Cancer Institute, Ankara, Turkey
| | - Ozturk Ates
- Hacettepe University School of Medicine, Ankara, Turkey
| | - Sercan Aksoy
- Hacettepe University Cancer Institute, Department of Medical Oncology, Ankara, Turkey
| | - Ali R Sever
- Hacettepe Univesity Radiology Department, Ankara, Turkey
| |
Collapse
|